Search Results

Retraction: Urinary neutrophil gelatinase-associated lipocalin and urinary soluble CXCL16 as biomarkers of activity in pediatric lupus nephritis

• Source: Indian Journal of Nephrology. Nov-Dec 2023, Vol. 33 Issue 6, 492

Record details

Lupus nephritis

• Source: Mayo Clinic Health Information Library. March 19, 2024

Record details

ImmPACT Bio Awarded $8 Million CIRM Grant for Phase 1b/2 Development of IMPT-514, a CD19/CD20 Bispecific CAR T-Cell Therapy for Refractory Lupus Nephritis and Systemic Lupus Erythematosus

• Source: Women's Health Weekly. March 14, 2024, 25

Record details

Data on Lupus Nephritis Discussed by Researchers at Hospital for Special Surgery (1111type I Interferon and Neutrophil Transcripts In Lupus Nephritis Renal Biopsies: Clinical and Histopathological Associations).

• Source: Health & Medicine Week. 2024, pages. 1332

Record details

Barraquer-Simons syndrome: An unusual form of acquired partial lipodystrophy in a child with lupus nephritis

• Authors : Mondal, Nirjhar; Mandal, Sudip; Nandy, Pramit

• Source: Indian Dermatology Online Journal. Nov-Dec 2023, Vol. 14 Issue 6, 890

Record details

Data on Lupus Nephritis Discussed by Researchers at Hospital for Special Surgery (1111type I Interferon and Neutrophil Transcripts In Lupus Nephritis Renal Biopsies: Clinical and Histopathological Associations)

• Source: Health & Medicine Week. February 9, 2024, p1332.

Record details

Noninvasive Evaluation of Lupus Nephritis Activity Using a Radiomics Machine Learning Model Based on Ultrasound

• Authors : Qin, Xiachuan; Xia, Linlin; Zhu, Chao

• Source: Journal of Inflammation Research. February 28, 2023, Vol. 16, p433, 9 p.

Record details

Everest Medicines and Kezar Life Sciences Get IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

• Source: Health & Beauty Close-Up. March 4, 2024

Record details

Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer NK Cell Therapy in Lupus Nephritis

• Source: Obesity, Fitness & Wellness Week. November 4, 2023, 41

Record details

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis.

• Source: Manufacturing Close-Up. 2024.

Record details